Neurolutions, Inc. Announces Groundbreaking CMS Decision for IpsiHand™
A Leap Forward in Stroke Rehabilitation The Centers for Medicare & Medicaid Services (CMS) has established a new Healthcare Common
Pioneering Medical Innovations
Pioneering Medical Innovations
A Leap Forward in Stroke Rehabilitation The Centers for Medicare & Medicaid Services (CMS) has established a new Healthcare Common
Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, announced the opening of
Leadership Appointments Move Ocular Towards Being a Leader in Retinal Care Screening Underway in AXPAXLI™ Phase 3 SOL-1 Trial for Wet AMD
NextPlane, a leading provider of interoperability and federation services for collaboration solutions, today announced a set of new software offerings
Industry Leader and Retina Expert, Pravin U. Dugel, MD, Becomes Executive Chair Jeffrey S. Heier, MD to become Chief Scientific
BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (Nasdaq:OCUL) (the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality
Strategic promotion underscores commitment to commercial growth across Ocular portfolio BEDFORD, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical
Gone are the days of isolated teams and clunky communication channels because seamless communication across platforms have become the lifeblood
Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, today released an analysis
Phase 3 SOL-1 study will evaluate the efficacy and safety of AXPAXLI in wet AMD BEDFORD, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE)